Geographic expansion and regulatory expertise: With an increasingly complex global regulatory environment, biopharma ...
Swarm Oncology Ltd., a biotechnology company, has partnered with Cellex Cell Professionals GmbH, a contract development and ...
GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...
The application was based on results from the three-arm Phase 3 CheckMate -8HW study.
Kineticos Life Sciences has launched Kinvard Bio Inc., a new anti-infectives biotech company based on research that has been ...
Maravai LifeSciences Inc., a provider of life science reagents and services to researchers and biotech innovators, has ...
AstraZeneca 4Q Revenues: $14.9 billion (+24%) 4Q Earnings: $1.5 billion (+56%) FY Revenues: $54.1 billion (+18%) FY Earnings: $7.0 billion (+18%) Comments: Oncology sales were $22.4 billion, up 21%.
Dr. Srinivas Rao, Co-Founder and CEO of atai, added, “This agreement strengthens our DMT patent portfolio and enables us to ...
Agreement allows Andelyn to use Stanton Lab CNS capsids to perform R&D services for clients developing gene therapies.
Ivor Elrifi, CEO of Tiziana Life Sciences, commented, “Partnering with Renaissance is a significant milestone in our mission ...
Eleva, a pioneer in unlocking difficult-to-produce biologics, has appointed Dr. Martin Bauer, MD, as its new Chief Medical ...
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results